Further support for targeting the CCR5 gene was provided by observation that its disruption by a naturally occurring 32 bp deletion (CCR5Δ32) confers protection from HIV infection in homozygotes for the mutated gene and delays disease progression in heterozygotes for the mutated gene [241,242,243]. Here, CCR5 is linked to HIV infectious disease.